News - Pharmaceutical
?Tender for pharmaceutical company to be called in January?
23 December 2012
?Tender for pharmaceutical company to be called in January?. Source: Tanjug. BELGRADE -- Finance and Economy Minister Mla?an Dinki? has announced that a tender for a strategic partner for Galenika pharmaceutical company will be called in January.
Click on the link to read the full article at B92 (This link will open in a new window)Genentech and other big pharmaceutical companies cash in on HGH sales
21 December 2012
A federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's biggest pharmaceutical companies, an Associated Press investigation shows.
Click on the link to read the full article at San Jose Mercury News (This link will open in a new window)Big, bad pharma: Why our relationship with the Pharmaceutical industry matters
21 December 2012
Over the past few decades, the pharmaceutical industry has dramatically changed shape. And as a society, our relationship with it has altered alongside. The pharmaceutical industry is dominated now by a few giant companies which merged with smaller ...
Click on the link to read the full article at The Independent (This link will open in a new window)AUSTRALIAN PHARMACEUTICAL INDUSTRIES LTD : Chairman's letter to ...
21 December 2012
On behalf of the Board of Directors of Australian Pharmaceutical Industries Limited (API), I am pleased to invite you to attend the 2012 Annual General Meeting. Enclosed is the Notice of Meeting and Proxy Form which sets out the items of business. In ...
Click on the link to read the full article at 4-traders (This link will open in a new window)ACCC rules pharmaceutical companies must reveal doctor payments
20 December 2012
The ACCC yesterday approved the pharmaceutical industry's latest Code of Conduct that governs how it deals with medicos, but ticked it off for just two years instead of the five years the industry had sought. The watchddog says it wants further ...
Click on the link to read the full article at Perth Now (This link will open in a new window)Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With ...
20 December 2012
NOVATO, Calif., Dec. 20, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that it has signed a $50 million loan agreement with HealthCare Royalty Partners ("HC Royalty") to help fund ...
Click on the link to read the full article at NASDAQ (This link will open in a new window)Sun Pharma - Caraco Pharmaceutical Laboratories announces Successful ...
20 December 2012
Sun Pharmaceutical Industries Ltd has submitted to BSE Press release issued in U.S.A. by the Company''s Subsidiary, Caraco Pharmaceutical Laboratories Ltd dated December 20, 2012 titled " Caraco Pharmaceutical Laboratories announces Successful ...
Click on the link to read the full article at Moneycontrol.com (This link will open in a new window)LEE'S PHARMACEUTICAL HOLDINGS LIMITED : Form of proxy for use at the ...
20 December 2012
Shatin, Hong Kong on 21 January 2013 at 3:00 p.m. (or at any adjournment thereof) for the purposes of considering and, if thought fit, passing the resolutions as set out in the notice convening the Meeting and at the Meeting (or at any adjournment ...
Click on the link to read the full article at 4-traders (This link will open in a new window)Call Spreads Trading in Achillion Pharmaceutical (ACHN)
19 December 2012
Earlier today, shares of Achillion Pharmaceutical (ACHN) are trading down.14 to $8.50. ACHN has recently traded as low as $7 in the last three months. Paper bought the ACHN Jan 10 calls and sold the Mar 12 calls for even money. The volume for the block ...
Click on the link to read the full article at The Options Insider (This link will open in a new window)Australian Pharmaceutical Patents Review underway
19 December 2012
The Australian government recently launched a review of pharmaceutical patent protection. Central to the review will be an analysis of the pharmaceutical extension of term provisions of the Patents Act 1990 (s.70). The review will consider whether ...
Click on the link to read the full article at Lexology (registration) (This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
